Jianbin Bi

1.5k total citations
61 papers, 1.1k citations indexed

About

Jianbin Bi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jianbin Bi has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 29 papers in Cancer Research and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jianbin Bi's work include Ferroptosis and cancer prognosis (18 papers), Cancer-related molecular mechanisms research (16 papers) and Epigenetics and DNA Methylation (16 papers). Jianbin Bi is often cited by papers focused on Ferroptosis and cancer prognosis (18 papers), Cancer-related molecular mechanisms research (16 papers) and Epigenetics and DNA Methylation (16 papers). Jianbin Bi collaborates with scholars based in China, Japan and Israel. Jianbin Bi's co-authors include Chuize Kong, Zeliang Li, Xiankui Liu, Yutao Wang, Yuyan Zhu, Jianfeng Wang, Zhe Zhang, Meng Yu, Jiaxing Lin and Jun Li and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and The Journal of Urology.

In The Last Decade

Jianbin Bi

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianbin Bi China 22 733 556 279 166 149 61 1.1k
Jiang Zhu China 21 692 0.9× 515 0.9× 168 0.6× 132 0.8× 177 1.2× 75 1.2k
Lian‐Di Liao China 24 1.1k 1.5× 505 0.9× 212 0.8× 165 1.0× 228 1.5× 63 1.5k
Yohei Sekino Japan 18 578 0.8× 317 0.6× 330 1.2× 122 0.7× 207 1.4× 88 916
Lixin Zheng China 14 655 0.9× 333 0.6× 390 1.4× 94 0.6× 141 0.9× 19 907
Guogui Sun China 18 604 0.8× 334 0.6× 165 0.6× 90 0.5× 170 1.1× 56 897
Zhongtao Zhang China 17 569 0.8× 480 0.9× 125 0.4× 137 0.8× 193 1.3× 44 906
Ye Song China 18 776 1.1× 507 0.9× 168 0.6× 55 0.3× 186 1.2× 44 1.1k
Andy Göbel Germany 17 471 0.6× 323 0.6× 156 0.6× 158 1.0× 298 2.0× 38 895
Yuanjie Niu China 20 703 1.0× 413 0.7× 582 2.1× 109 0.7× 279 1.9× 49 1.2k
So Mee Kwon South Korea 18 510 0.7× 337 0.6× 140 0.5× 143 0.9× 199 1.3× 29 892

Countries citing papers authored by Jianbin Bi

Since Specialization
Citations

This map shows the geographic impact of Jianbin Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianbin Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianbin Bi more than expected).

Fields of papers citing papers by Jianbin Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianbin Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianbin Bi. The network helps show where Jianbin Bi may publish in the future.

Co-authorship network of co-authors of Jianbin Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Jianbin Bi. A scholar is included among the top collaborators of Jianbin Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianbin Bi. Jianbin Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
5.
Hu, Jiyuan, Zhenyu Wang, Hao Hu, et al.. (2023). In vitro and in vivo assessment of a bilayered degradable rapamycin-eluting stent for ureteral stricture caused by holmium: YAG laser lithotripsy. Acta Biomaterialia. 172. 321–329. 9 indexed citations
6.
Sun, Shanshan, et al.. (2022). An HDAC9-associated immune-related signature predicts bladder cancer prognosis. PLoS ONE. 17(3). e0264527–e0264527. 4 indexed citations
8.
Wang, Yutao, et al.. (2022). In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer. Functional & Integrative Genomics. 22(5). 797–811. 12 indexed citations
9.
Wang, Yutao, et al.. (2021). Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology. BMC Cancer. 21(1). 727–727. 20 indexed citations
10.
Wang, Yutao, et al.. (2021). M2 Macrophage Co-Expression Factors Correlate With Immune Phenotype and Predict Prognosis of Bladder Cancer. Frontiers in Oncology. 11. 609334–609334. 25 indexed citations
11.
Sun, Shanshan, et al.. (2021). A novel immune-related gene pair prognostic signature for predicting overall survival in bladder cancer. BMC Cancer. 21(1). 810–810. 7 indexed citations
12.
Yang, Lei, et al.. (2020). Treatment of recurrent renal transplant lithiasis: analysis of our experience and review of the relevant literature. BMC Nephrology. 21(1). 238–238. 7 indexed citations
13.
Liu, Zhuonan, Tianshui Sun, Zhe Zhang, Jianbin Bi, & Chuize Kong. (2020). An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer. Genomics. 113(1). 896–907. 27 indexed citations
14.
Wang, Yu, et al.. (2019). Analysis of imaging and pathological features of renal neoplasms among different pathological types. Zhonghua miniao waike zazhi. 40(5). 374–379. 1 indexed citations
15.
Zhang, Xiaotong, Chiyuan Piao, Jianbin Bi, et al.. (2019). A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma. Biomedicine & Pharmacotherapy. 118. 109079–109079. 21 indexed citations
16.
Zhang, Naiwen, Jianyu Yang, Yuyan Zhu, et al.. (2019). Long non-coding RNA ZEB1-AS1 regulates miR-200b/FSCN1 signaling and enhances migration and invasion induced by TGF-β1 in bladder cancer cells. Journal of Experimental & Clinical Cancer Research. 38(1). 111–111. 56 indexed citations
17.
Bi, Jianbin, Jingyao Zhang, Simin Zhang, et al.. (2017). Hydrogen-rich water protects against inflammatory bowel disease in mice by inhibiting endoplasmic reticulum stress and promoting heme oxygenase-1 expression. World Journal of Gastroenterology. 23(8). 1375–1375. 32 indexed citations
18.
Kong, Chuize, et al.. (2017). TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth. Oncology Reports. 38(4). 1967–1976. 36 indexed citations
19.
Shen, Hailin, et al.. (2010). Expression and significance of fascin and Ki-67 proteins in bladder carcinoma.. 39(2). 135–137. 1 indexed citations
20.
Zhu, Yuyan, Meng Yu, Zhenhua Li, et al.. (2010). ncRAN, a Newly Identified Long Noncoding RNA, Enhances Human Bladder Tumor Growth, Invasion, and Survival. Urology. 77(2). 510.e1–510.e5. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026